Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Queensland Health
Harvard Business School
Fuji
Express Scripts
Medtronic
Chinese Patent Office
Moodys

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RENVELA

« Back to Dashboard

Clinical Trials for Renvela

Trial ID Title Status Sponsor Phase Summary
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed DaVita Dialysis N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Fresenius Medical Care North America N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Genzyme, a Sanofi Company N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Novartis Pharmaceuticals N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Shire N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD Completed Denver Nephrologists, P.C. N/A The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Renvela

Condition Name

Condition Name for Renvela
Intervention Trials
Chronic Kidney Disease 6
Hyperphosphatemia 4
Healthy 2
Insulin Sensitivity 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Renvela
Intervention Trials
Kidney Diseases 11
Renal Insufficiency, Chronic 9
Kidney Failure, Chronic 6
Hyperphosphatemia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Renvela

Trials by Country

Trials by Country for Renvela
Location Trials
United States 82
Puerto Rico 3
Italy 2
Austria 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Renvela
Location Trials
New York 7
California 6
Texas 6
Colorado 5
Illinois 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Renvela

Clinical Trial Phase

Clinical Trial Phase for Renvela
Clinical Trial Phase Trials
Phase 4 2
Phase 3 5
Phase 2 5
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Renvela
Clinical Trial Phase Trials
Completed 14
Recruiting 4
Unknown status 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Renvela

Sponsor Name

Sponsor Name for Renvela
Sponsor Trials
Genzyme, a Sanofi Company 7
Shire 3
Fresenius Medical Care North America 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Renvela
Sponsor Trials
Industry 20
Other 15
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
US Department of Justice
Cerilliant
Accenture
Chubb
Express Scripts
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.